Spread the research net wider to find the solutions to aging

BSRA Chair calls for greater interaction between industry and academia to ensure that no stone is left unturned in the quest to understand aging.

Next month, the British Society for Research on Aging will host its annual meeting, bringing together a compelling mix of academic researchers on aging and companies developing longevity therapeutics. With the likes of National University of Singapore professor Brian Kennedy and the Max Planck Institute’s Dr Joris Deelen speaking alongside Altos Labs PI Martin Denzel and Loyal founder Celine Halioua, there is a clear focus on bringing longevity research and industry together.

My take on this: In the last few years, the landscape for aging research has changed considerably, thanks to a huge influx of investment into the emerging longevity biotech sector. As the saying goes, a rising tide floats all boats, but the worlds of research and industry are often seen as worlds apart. Longevity.Technology caught up with the BSRA’s new Chair, Durham University Associate Professor David Weinkove, about his vision for the future of aging research.

The wide-ranging and complex nature of aging is something that Weinkove believes is a challenge for researchers in the field.

“It can sometimes be difficult for researchers to talk to each other because they're coming from different fields within aging,” he says. “At one end of the spectrum you’ve got the fundamental molecular biology and biochemistry – how protein or DNA changes with age. Then you’ve got things like cell biology, genetics, organs, physiology, all the way up to aging societies, sports medicine, and all the rest.

“If you talk to all these different people working on different subjects, they always think their thing is the key to aging – and I’m as guilty of that as anyone else!”

Read the full article HERE.

Thanks for reading! If you’ve enjoyed this article, it would mean a lot to me if you could subscribe and share it on LinkedIn!